Ropivacaine Hydrochloride Injection, USP, 0.5%, 500 mg per 100 mL (5mg/mL), Manufactured by: Amneal Pharmaceuticals Pvt. Ltd., Mehsana, India, , Distributed by: Amneal Pharmaceuticals LLC, Bridgewater, NJ 08807 NDC 70121-1734-1 (bag); NDC 70121-1734-3 (box)
Published May 14, 2025 · Recall initiated: April 17, 2025
Summary
FDA records drug Class I recall D-0402-2025, published May 14, 2025 and initiated April 17, 2025. Recalling firm: Amneal Pharmaceuticals, LLC; Status: Ongoing; Reported quantity: 62 (12x100mL) bags; Lot: Lot #'s: AL240003, AL240004, Exp.: 01/31/2026. Class I means a reasonable probability of serious adverse health consequences or death.
Status when published: Ongoing — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
Presence of Particulate Matter
What to do
Voluntary: Firm initiated · Letter
Get an email if ROPIVACAINE HYDROCHLORIDE has another recall
Free. We only write when there's a new recall that matches. Unsubscribe in one click.
Recall details
- Brand
- ROPIVACAINE HYDROCHLORIDE
- Manufacturer
- Amneal Pharmaceuticals, LLC
- Distributor
- Nationwide in the US
- UPC
- 0370121173533
- Lot
- Lot #'s: AL240003, AL240004, Exp.: 01/31/2026
- Risk classification
- Class I
- Area (FDA)
- drug
- Country
- United States
Related recalls
- FDATimolol Maleate Ophthalmic Solution USP, 0.5%, Sterile, 10mL bottles, Rx only, Manufactured by: FDC Limited,May 14, 2025
- FDAArtificial Tears Ophthalmic Solution, Dextran 70.01%/Glycerin 0.2%/Hypromellose 0.3% (Eye Lubricants)May 14, 2025
- FDACarboxymethylcellulose Sodium Ophthalmic Gel 1%, Carboxymethlycellulose Sodium 1% Eye Lubricant, Lubricant EyeMay 14, 2025
- FDAMedline procedure kits, labeled as: 1) STERILE PREP KIT, REF DYNDA1359A; 2) STRL EK SINGLE PACK, REFMay 7, 2025
- FDAMedline procedure kits, labeled as: T AND A PACK -LF, REF DYNJ85792May 7, 2025
- FDAMedline Sterile 0.9% Normal Saline, USP, 100mL, REF RDI30296May 7, 2025
Questions about this recall
Was Ropivacaine Hydrochloride Injection, USP, 0.5%, 500 mg per 100 mL (5mg/mL), Manufactured by: Amneal Pharmaceuticals Pvt. Ltd., Mehsana, India, , Distributed by: Amneal Pharmaceuticals LLC, Bridgewater, NJ 08807 NDC 70121-1734-1 (bag); NDC 70121-1734-3 (box) recalled?
Yes. FDA published recall D-0402-2025 on May 14, 2025. Reported hazard: Presence of Particulate Matter
What should I do if I have this product?
Voluntary: Firm initiated · Letter
How do I know if my unit is part of the recall?
Compare your product details with the notice. Brand: ROPIVACAINE HYDROCHLORIDE. UPC: 0370121173533.